difficult to evaluate the degree of the paralysis through the videostroboscopy. The author studied voice range profile (VRP) to evaluate patients who have high pitch dysphonia after thyroidectomy. METHOD: A prospective study was performed with 67 patients who underwent voice examination preoperatively, 1 week and 3 months after the thyroidectomy. The patients included 58 females and 9 males. Six female patients showed high pitch dysphonia. The patients were classified as the group of female with no high pitch dysphonia (group A, nϭ52), the group of female with high pitch dysphonia (group B, nϭ6) and the group of male (group C, nϭ9). VRP was performed to identify the frequency range and the intensity range, Laryngeal electromyogram (EMG) was performed in group B. RESULTS: In Group B, the frequency range was 443.1183.97 Hz, 246.6749.41 Hz, 181.3780.13 Hz showing significant decrease at 1 week and 3 months after the surgery compared to that of the preoperative result (pϽ0.05). In addition, the intensity range was 22.252.87 dB, 15.252.22 dB, 16.252 .63 dB respectively showing significant postoperative decrease (pϽ0.05). EMG of group B showed decreased potential with 3 patients, normal potential in 2, and the other patient refused to take the exam. In group A and C, VRP revealed no significant difference between the preoperative and postoperative results. CONCLUSION: VRP test is a easy and practical test which demonstrates decreased frequency range visually and helps to evaluate EBSLN injury within 5 minutes.
VTE in Head & Neck Cancer Patients After Surgery
Neil Gross, MD (presenter); Mark Wax, MD; Peter Andersen, MD OBJECTIVE: Cancer patients undergoing major surgery are considered high risk for venous thromboembolism (VTE). The risk of VTE in head and neck cancer patients undergoing surgical ablation is unknown. The purpose of this study was to report the incidence of VTE in head and neck cancer patients after extensive resection and microvascular reconstruction and to explore the impact of VTE on survival. METHOD: Single-institution, retrospective cohort study performed between 2007 and 2009; 134 head and neck cancer patients underwent a total of 139 procedures. All patients underwent extensive cancer resection and simultaneous microvascular free tissue transfer reconstruction. Demographic, clinical and surgical data were abstracted for all cases. The primary endpoint was identification of confirmed (pulmonary embolism, PE; deep venous thrombosis, DVT) or suspicious (acute respiratory failure, sudden cardiac arrest, leg edema without imaging) cases of VTE within 30 days of surgery. The association between covariates and VTE were assessed using multivariable logistic regression analysis and Kaplan -Meier survival analysis.
RESULTS:
Most patients were male (59%) with head and neck squamous cell carcinoma (76%). The mean patient age was 65.4 years. A total of eight (5.8%) confirmed or suspicious VTE were identified; one PE, one DVT, one acute respiratory failure, one sudden cardiac arrest, and four cases of leg edema. Risk factors for VTE included older age, female gender, tobacco smoking, high body mass index (BMI), prior history of VTE, prolonged operation time, prolonged hospitalization, and perioperative red blood cell transfusion. In the multivariable analysis, the strongest predictors of VTE were a prior history of VTE (pϭ0.04; odds ratio [OR], 25.11; 95% confidence interval [CI], 1.13-556.40), red cell transfusion (pϭ0.009; OR, 1.80; CI, 1.16-2.80), high BMI (pϭ0.015, OR, 1.29, CI, 1.05-1.58), and older age (pϭ0.046; OR, 1.10; CI, 1.00-1.19). In multivariate models, confirmed VTE and suspicious VTE were significant predictors of decreased two-year survival (hazard ratioϭ2.87, 95% CI, 1.39-17.08, p ϭ 0.019) and (HRϭ1.79, 95% CI, 1.11-6.50, p ϭ 0.019), respectively, when stratified against non-VTE patients. CONCLUSION: The incidence of VTE in head and neck cancer patients after major surgery involving microvascular reconstruction, ranged from 1.4% (confirmed) to 5.8% (confirmed and suspicious). These results suggest that the incidence of VTE may be underestimated in head and neck cancer patients after extensive resection and microvascular reconstruction. Prospective studies are needed to define the true extent of this problem.
WBC Differential Count for Diagnosis of Lymphadenopathy
Soon-Hyun Ahn, MD, PhD (presenter) OBJECTIVE: Cervical lymphadenopathy is one of the most common presentations in the head and neck field, and self limiting reactive hyperplasia or subacute necrotizing lymphadenitis is frequent. But differential diagnosis of the tuberculous lymphadenitis, metastatic carcinoma, benign mass, and lymphoma is sometimes not easy, and fine needle aspiration gives little information many times. The purpose of this study is to evaluate whether the differential count of white blood cells can help the decision making of the necessity of excisional biopsy rather than observation. METHOD: From October 2007 to December 2009, 175 patients were included in study. All patients visited the outpatient clinic due to the cervical lymphandenopathy and performed fine-needle aspiration and complete blood cell count with white blood cell differential count. RESULTS: The last diagnosis was reactive hyperplasia in 104 patients (59.4%) and subacute necrotizing lymphadenitis in 18 patients (10.3%). So 69.7% of patients showed self limiting course. There were 19 tuberculous lymphadenitis, 12 benign mass other than lymphadenitis, 13 metastatic carcinoma, and nine lymphoma. The fine needle aspiration biopsy could detect ten metastatic carcinoma and four lymphoma, and the detec-
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